0001209191-20-035110.txt : 20200608
0001209191-20-035110.hdr.sgml : 20200608
20200608185947
ACCESSION NUMBER: 0001209191-20-035110
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191001
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Muller Lorenz
CENTRAL INDEX KEY: 0001771207
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38899
FILM NUMBER: 20950463
MAIL ADDRESS:
STREET 1: C/O MILESTONE PHARMACEUTICALS, INC.
STREET 2: 1111 DR. FREDERIK-PHILIPS BLVD., STE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001408443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
BUSINESS PHONE: (514) 336-0444
MAIL ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-01
0
0001408443
Milestone Pharmaceuticals Inc.
MIST
0001771207
Muller Lorenz
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTR?AL
A8
H4M 2X6
QUEBEC, CANADA
0
1
0
0
Chief Commercial Officer
Common Shares
2019-10-01
4
M
0
2500
1.54
A
52115
D
Common Shares
2020-04-03
4
M
0
32528
1.54
A
84643
D
Common Shares
2020-04-03
4
M
0
18043
1.54
A
102686
D
Employee Stock Option (right to buy)
1.54
2019-10-01
4
M
0
2500
0.00
D
2027-10-11
Common Shares
2500
87982
D
Employee Stock Option (right to buy)
1.54
2020-04-03
4
M
0
32528
0.00
D
2027-10-11
Common Shares
32528
55454
D
Employee Stock Option (right to buy)
1.54
2020-04-03
4
M
0
18043
0.00
D
2028-10-15
Common Shares
18043
32903
D
Employee Stock Option (right to buy)
3.74
2020-06-05
4
A
0
35000
0.00
A
2030-06-05
Common Shares
35000
35000
D
The original grant was for 140,100 option shares. Twenty-five percent (25%) of the shares subject to the option vested on October 11, 2018, and
one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person
continuing to provide service through each such date.
The original grant was for 50,946 option shares. Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining
shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such
date.
The shares subject to this option shall vest in twenty-four (24) equal monthly installments commencing on July 5, 2020, subject to the recipient continuing to provide service to the Issuer through each such date.
/s/ Eric Popp, Attorney-in-Fact
2020-06-08